| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2020 | Mar 16, 2020 | Enliven Therapeutics, Inc. | Director | Buy | 100.0 | +187,500 | 15.06% | ✗ | $3M |
| May 9, 2019 | May 13, 2019 | Trevi Therapeutics, Inc. | Director | Buy | 100.0 | +375,000 | 48.29% | ✗ | $3.8M |
| Nov 21, 2017 | Feb 13, 2018 | scPharmaceuticals Inc. | Director | Buy | 100.0 | +654,762 | 25.89% | ✗ | $9.2M |